Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Julphar
Healthtrust
Colorcon
Argus Health
Medtronic

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 7,083,784

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,083,784
Title:Molecules with extended half-lives, compositions and uses thereof
Abstract: The present invention provides molecules, including IgGs, non-IgG immunoglobulin, proteins and non-protein agents, that have increased in vivo half-lives due to the presence of an IgG constant domain, or a portion thereof that binds the FcRn, having one or more amino acid modifications that increase the affinity of the constant domain or fragment for FcRn. Such proteins and molecules with increased half-lives have the advantage that smaller amounts and or less frequent dosing is required in the therapeutic, prophylactic or diagnostic use of such molecules.
Inventor(s): Dall\'Acqua; William (Gaithersburg, MD), Johnson; Leslie S. (Germantown, MD), Ward; Elizabeth Sally (Dallas, TX)
Assignee: MedImmune, Inc. (Gaithersburg, MD)
Application Number:10/020,354
Patent Claims:see list of patent claims

Details for Patent 7,083,784

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Medimmune SYNAGIS palivizumab VIAL 103770 002 1998-06-19 ➤ Sign Up MedImmune, Inc. (Gaithersburg, MD) ➤ Sign Up RX search
Medimmune SYNAGIS palivizumab VIAL 103770 001 1998-06-19 ➤ Sign Up MedImmune, Inc. (Gaithersburg, MD) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,083,784

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 02060919 Aug 08, 2002
World Intellectual Property Organization (WIPO) 02060919 Jan 03, 2003
World Intellectual Property Organization (WIPO) 02060919 Sep 04, 2003
United States of America 2003190311 Oct 09, 2003
United States of America 2006198840 Sep 07, 2006
United States of America 2007122403 May 31, 2007
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKinsey
McKesson
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.